← Back to Search

Behavioral Intervention

GYNCOG Intervention for Vulvar Cancer (GYNCOG Trial)

N/A
Waitlist Available
Led By Emma Barber, MD, MS
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Female; ≥18 years of age
* Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
No Placebo-Only Group

Summary

The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.

Eligible Conditions
  • Cervical Cancer
  • Vulvar Cancer
  • Ovarian Cancer
  • Uterine Cancer
  • Endometrial Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Assessment Compliance
Secondary study objectives
Acceptability
Change in Anxiety
Change in Depression
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GYNCOG InterventionExperimental Treatment1 Intervention
Participants in the GYNCOG arm will be asked to participate in a home-based cognitive training program utilizing BrainHQ on study-provided tablets.
Group II: Control GroupActive Control1 Intervention
Patients in the Control Group arm will receive usual care with no cognitive intervention.

Find a Location

Who is running the clinical trial?

Friends of PrenticeOTHER
5 Previous Clinical Trials
824 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,638 Previous Clinical Trials
957,433 Total Patients Enrolled
Emma Barber, MD, MSPrincipal InvestigatorNorthwestern University
4 Previous Clinical Trials
324 Total Patients Enrolled
~40 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top